⌘K

Login Start Free

Home/Filings/4/0001855763-24-000010

4//SEC Filing

Carle Vanessa 4

Accession 0001855763-24-000010

CIK 0001348362other

View on SEC.gov Company Profile

Filed

May 9, 8:00 PM ET

Accepted

May 10, 5:24 PM ET

Size

13.6 KB

Accession

0001855763-24-000010

Insider Transaction Report

Form 4

Period: 2024-04-26

Lexaria Bioscience Corp.LEXX

Secretary

Transactions

Award
Stock Options
2024-04-26+10,000→ 62,567 total
Exercise: $2.36From: 2024-04-26Exp: 2029-04-26→ Common Shares (10,000 underlying)

Holdings

Stock Options
Exercise: $3.00From: 2021-06-08Exp: 2026-06-08→ Common Shares (5,000 underlying)
17,567
Stock Options
Exercise: $3.00From: 2021-09-01Exp: 2026-09-01→ Common Shares (10,000 underlying)
27,567
Stock Options
Exercise: $2.91From: 2022-08-29Exp: 2027-08-29→ Common Shares (12,500 underlying)
40,067
Stock Options
Exercise: $1.15From: 2023-10-26Exp: 2028-10-26→ Common Shares (12,500 underlying)
52,567
common shares
67
Warrants
Exercise: $36.00From: 2019-11-13Exp: 2024-11-13→ Common Shares (67 underlying)
67
Stock Options
Exercise: $3.00From: 2021-04-26Exp: 2026-04-26→ Common Shares (12,500 underlying)
12,567

Footnotes (3)

[F1]Repriced from $5.31 pursuant to shareholder approval received May 9, 2023
[F2]Repriced from $7.08 pursuant to shareholder approval received May 9, 2023
[F3]Repriced from $6.23 pursuant to shareholder approval received May 9, 2023

Documents

1 file

4
primary_doc.xmlPrimary
PRIMARY DOCUMENT

Issuer

Lexaria Bioscience Corp.

CIK 0001348362

Entity typeother

Related Parties

1

filerCIK 0001855763

Filing Metadata

Form type: 4
Filed: May 9, 8:00 PM ET
Accepted: May 10, 5:24 PM ET
Size: 13.6 KB

View on SEC.gov